H. ÖZDEN Et Al. , "The effects of levetiracetam on urinary 15f-2t-isoprostane levels in epileptic patients," SEIZURE-EUROPEAN JOURNAL OF EPILEPSY , vol.19, no.8, pp.514-516, 2010
ÖZDEN, H. Et Al. 2010. The effects of levetiracetam on urinary 15f-2t-isoprostane levels in epileptic patients. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY , vol.19, no.8 , 514-516.
ÖZDEN, H., CANBAZ KABAY, S., Toker, A., ÜSTÜNER, M. C., ÖZBAYER, C., AKYILDIZ ÜSTÜNER, D., ... Gunes, H. V.(2010). The effects of levetiracetam on urinary 15f-2t-isoprostane levels in epileptic patients. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY , vol.19, no.8, 514-516.
ÖZDEN, HİLMİ Et Al. "The effects of levetiracetam on urinary 15f-2t-isoprostane levels in epileptic patients," SEIZURE-EUROPEAN JOURNAL OF EPILEPSY , vol.19, no.8, 514-516, 2010
ÖZDEN, HİLMİ Et Al. "The effects of levetiracetam on urinary 15f-2t-isoprostane levels in epileptic patients." SEIZURE-EUROPEAN JOURNAL OF EPILEPSY , vol.19, no.8, pp.514-516, 2010
ÖZDEN, H. Et Al. (2010) . "The effects of levetiracetam on urinary 15f-2t-isoprostane levels in epileptic patients." SEIZURE-EUROPEAN JOURNAL OF EPILEPSY , vol.19, no.8, pp.514-516.
@article{article, author={HİLMİ ÖZDEN Et Al. }, title={The effects of levetiracetam on urinary 15f-2t-isoprostane levels in epileptic patients}, journal={SEIZURE-EUROPEAN JOURNAL OF EPILEPSY}, year=2010, pages={514-516} }